New coronavirus emergency clearances: BioCore, SolGent, Seasun, P23 Labs

LabPulse.com staff writers
May 21, 2020
2019 05 02 23 38 2538 Check Mark 400

The U.S. Food and Drug Administration granted four new emergency use authorizations for COVID-19 polymerase chain reaction (PCR) testing products, including a test cleared for use with saliva samples collected at home from P23 Labs of Little Rock, AR.

Authorizations were granted to the following products on May 21:

  • P23 Labs' TaqPath SARS-CoV-2 Assay
  • BioCore's 2019-nCoV Real Time PCR kit
  • SolGent's DiaPlexQ Novel Coronavirus (2019-nCoV) detection kit
  • Seasun Biomaterials' AQ-TOP COVID-19 rapid detection kit
Latest in Infectious
Antibiotic Resistant Bacteria Social
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
December 1, 2023
Sepsis Bacteria Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
November 22, 2023
Bacteria Blood Sepsis Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
November 20, 2023
Money Hundred Bills Social
Cytovale raises $84M in series C funding
November 16, 2023
Related Stories
2020 02 25 23 24 4831 Lab Microscope Woman 400
Emergency Use Authorization
Phosphorus, BioIq partner on COVID-19 saliva self-test
2020 03 20 23 29 9036 Virus Coronavirus Microscope 400
Influenza
BioIQ, P23 launch home saliva panel test for COVID-19, flu
2020 03 12 17 37 4721 Virus Coronavirus3 400
Infectious
FDA clears Phosphorus' home SARS-CoV-2 saliva test
2020 04 16 18 56 8041 Virus Coronavirus Sars Co V 2 400
Sequencing
Swift debuts kit for novel coronavirus
More in Infectious
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.
December 1, 2023
Antibiotic Resistant Bacteria Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Sepsis Bacteria Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Bacteria Blood Sepsis Social
Cytovale raises $84M in series C funding
Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.
November 16, 2023
Money Hundred Bills Social
Illumina launches pricing program for pathogen sequencing tools in LMICs
Illumina has launched its Global Health Access Initiative program to provide pathogen sequencing tools at lower prices in low- and middle-income countries (LMICs).
November 13, 2023
Infectious Diseases Research Social
AI model could predict viral mutation, aid vaccine design
Researchers have developed a new artificial intelligence (AI) tool which they say could help predict new viral variants before they emerge.
October 31, 2023
Sequencing Virus Social
WHO launches expert review panel for NTD diagnostics
The World Health Organization (WHO) has created a pilot scheme for an expert review panel for diagnostic products as part of its program for neglected tropical diseases (NTDs).
October 13, 2023
Infectious Diseases Research Social
NIH researchers develop PCR assay for easier diagnosis of river blindness
U.S. National Institutes of Health (NIH) researchers have developed a new PCR assay to detect Onchocerca volvulus, the parasite that causes onchocerciasis, or river blindness, and are working to adapt it for easier field diagnosis of the disease.
October 9, 2023
Test Tubes Social
BioMérieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
September 29, 2023
Test Tube Liquid Sample Social
Study shows malaria drug resistance occurring in Horn of Africa
Malaria parasites in eastern Africa have developed resistance to artemisinins, essential first-line drugs used in combination therapies, jeopardizing the progress made in recent decades against the disease.
September 29, 2023
Plasmodium Falciparum Malaria Cdc Social
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Dna Sequencing2
Some emergency sepsis screening tools inadequate, EU study suggests
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Sepsis Bacteria Social
Page 1 of 148
Next Page